Schedule at a Glance


Note: All session times in the Advance Program, Schedule at a Glance, and Program Index are listed in Eastern Daylight Time.
Friday, October 2, 2020
9:30 AM – 7:30 PM
Saturday, October 3, 2020
10:00 AM – 6:00 PM
Translational and Clinical Research Course (TCRC)
  • Clinical and Translational Research in Stroke: Model for Innovation and Technology in Design and Conduct
  • Conducting Translational Research in Academia
  • Development of Neurological Therapies: Update from 30,000 Feet
  • Innovations in Design of Clinical Investigations and Trials
  • Keys to Getting Funded Without a K
  • Leading and Utilizing the CTSI
  • Starting and Developing a Successful Career as a Clinical Trialist
  • The Intramural NIH Research Experience
  • The Path to Achieving K-Level Funding
  • Treatments and Guidelines: Paths to Clinical Application
  • Trial Innovation Networks and Multisite Research
7:00 PM – 8:00 PM
Sunday, October 4, 2020
8:00 AM – 9:00 PM
10:00 AM – 12:15 PM
Presidential Symposium: Leveraging Digital Technologies*
  • Deep Phenotyping of Parkinson's Disease Using Digital Technology
  • Developing Novel Outcome Measures for Clinical Trials
  • Digital Therapeutics
  • High-Performance Digital Biomarkers: Ethomic Markers for Rapid, Precise Monitoring of Disease Progression
  • Precision Rehabilitation Strategies for Motor Recovery Post Stroke
12:30 PM – 2:30 PM
Derek Denny Brown Symposium
  • Bedside to Bench and Back Again: New Insights into Tau Biology and Therapeutics
  • Cerebellar Circuitry of Essential Tremor
  • Functional Genomics of Alzheimer's Disease
3:00 PM – 4:00 PM
Emerging Scholar Lectures 1 (NEW!)
  • An Undiagnosed White Matter Disorders Neurogenetics Clinic
  • Loss of Chchd2 and Chchd10 Activates Oma1 Peptidase to Disrupt Mitochondrial Cristae Phenocopying Patient Mutations
  • Objective Dystonia Identification Helps Elucidate Dystonia Pathophysiology
  • The Power of Single Cell Technologies; from T Cell Receptor to Antigen(s) in Multiple Sclerosis
4:30 PM – 6:30 PM
Targeting Glia for Therapy: Mediators of Neuroinflammation, Degeneration and Repair
  • Glia-Mediated Mechanisms of Chemotherapy-Related Cognitive Impairment
  • Oligodendrocyte Precursor Cell Present Antigen and are Cytotoxic Targets in Inflammatory Demyelination
  • Single Nuclei Transcriptomic Profiling of Human Astrocytes in Alzheimer’s Disease and Aging
  • Targeting Microglia-Mediated Synapse Elimination for Therapeutic Intervention in Demyelinating Disease
7:15 PM – 9:00 PM
Monday, October 5, 2020
8:00 AM – 7:30 PM
10:00 AM – 12:00 PM
Genomics of Personalized Medicine
  • CRISPR-Mediated Therapeutics for Duchenne Muscular Dystrophy
  • Genetic Discovery and Translation in Neuromuscular Diseases
  • Genomic Approaches Paving the Way for Precision Neurology
  • Patient-Customized Antisense Therapies for Rare Neurogenetic Diseases
  • Towards Primary Prevention of Genetic Prion Disease
12:15 PM – 1:45 PM
2:00 PM – 3:00 PM
Emerging Scholar Lectures 2 (NEW!)
  • Chemically Patterned Hydrogel Scaffolds Provide Cell-assembled Matrices to Guide Spinal Cord Regeneration
  • FTH1De Novo Dominant Variants Alter Iron Metabolism and Cause a Pediatric Onset Neuroferritinopathy
  • Neuropathy-causing TRPV4 Mutations Disrupt TRPV4-RhoA Interactions and Impair Cytoskeletal Regulation
  • Schwann Cells with Fig4 Deficiency are Predisposed to Demyelination
3:00 PM – 3:30 PM
3:30 PM – 5:45 PM
Microenvironment Control of Brain Tumor Pathogenesis
  • Immune System Cell Regulation of Brain Tumor Pathobiology
  • Neuronal Regulation of Brain Tumor Pathobiology
  • Self-organization of the Microenvironment Determines Glioma Pathogenesis
  • The Brain Microenvironment and Metastasis
6:00 PM – 7:30 PM
Tuesday, October 6, 2020
8:00 AM – 7:30 PM
10:00 AM – 11:30 AM
Course 1: View from the NINDS, NIA, NICHD, DoD, and VA
Early (Student, Resident, Trainee, Post-Doc Fellow) & Early to Mid-Career Level
11:30 AM – 12:00 PM
12:00 PM – 1:15 PM
Emerging Neurological Infections
  • Emerging Arboviral Infections
  • Novel Techniques for Diagnosis of CNS Infections
  • Update on Acute Flaccid Myelitis & Enterovirus-D-68
Recent Advances in Amyloidosis: A Disease You Can't Afford to Miss
  • Amyloid Polyneuropathy
  • Cerebral Amyloid Angiopathy
  • New and Emerging Therapies for Amyloidosis
12:00 PM – 2:00 PM
Global Neurology
  • Asylum-Seekers and Refugees in the U.S.: A Humanitarian Crisis
  • Clinician Educators in Global Health: Developing Neurological Care and Training in Zambia
  • Clinician-Educators in Global Health
  • Global Health at Home: Underserved Populations in the U.S.
1:45 PM – 2:30 PM
3:00 PM – 5:00 PM
ANA-AHS Headache
  • Migraine Pathophysiology: Focus on Neurovascular Activity and the Sleep-Wake State
  • Migraine Treatment: An Update
  • New Migraine Therapeutic Targets: The Potential of ASICs and TRP Channels
Behavioral Neurology
  • Early Involvement of Amygdala in Limbic-predominant Age-related TDP-43 Encephalopathy (LATE)
  • Selective Vulnerability in Frontotemporal Dementia
  • The Upper Motor Neurons with TDP-43 Pathology Display Distinct Cellular Defects
  • AI and Big Data for Critical Care EEG
  • Nonconvulsive Status Epilepticus: Evaluation and Treatment
  • Utilization of Status Guidelines and Continuous Video EEG Monitoring in the ICU
Neuromuscular Disease
  • Congenital Myopathies: New Advances in Therapy Development
  • Immunologic Biomarkers in Autoimmune Neuromuscular Disease
  • Neuromuscular Immune Related Adverse Events of Immune Checkpoint Inhibitor Therapies: Towards Risk Mitigation and Targeted Therapies
5:00 PM – 6:00 PM
6:00 PM – 7:30 PM
Wednesday, October 7, 2020
8:00 AM – 7:30 PM
10:00 AM – 11:30 AM
Course 2: Skills Development for Success in Research
Early (Student, Resident, Trainee, Postdoc Fellow) Career Level
  • Being a Good Mentee
  • Obtaining Advanced Training
  • Writing Effective Manuscripts
11:30 AM – 12:30 PM
12:30 PM – 1:45 PM
The Gene Therapy Toolbox: AAV
  • Introduction to AAV as a Delivery Vehicle for Gene Therapy in Neurology
  • Lessons from Completed on Ongoing AAV Gene Therapy Studies in Parkinson's Disease
  • Therapeutic Approaches using AAV: Gene Transfer, Silencing and Editing
2:00 PM – 3:00 PM
Emerging Scholar Lectures 3 (NEW!)
  • APOE Genotype Regulates Pathology and Disease Progression in Synucleinopathy
  • Cognitive Impairment and Risk Factors of LATE, a Novel Degenerative Pathology
  • Critical Glial Role For Parkinson's Disease Risk Genes In Controlling Alpha-synuclein Toxicity
  • Disparities in Access to Care and Research Participation in Advanced Parkinson's Disease: Differences Between a Home Visit Study and Outpatient Clinic Population
3:30 PM – 5:30 PM
Multiple Sclerosis*
  • CNM-Au8: Nanocatalytic Therapy for the Treatment of Chronic Optic Neuropathy
  • Neuroimaging Outcomes for Neuroprotection in MS: A Focus on the Retina
  • Remyelination Alters the Pattern of Myelin in the Cerebral Cortex
Neurocritical Care
  • Neurocritical Care in the Era of COVID-19
Traumatic Brain Injury
  • Imaging Consciousness: fMRI, Connectomics and the Ascending Arousal Network
  • Stimulating Consciousness with a Shock to the System: from DBS to Dopamine to Tweaking the Corticothalamic Axis
  • Tapping the Brain of the Comatose with EEG: Impairment and Recovery of Consciousness in the Critical Care Setting
5:30 PM – 6:00 PM
6:00 PM – 7:30 PM
Thursday, October 8, 2020
8:00 AM – 7:30 PM
10:00 AM – 11:30 AM
Course 3: Landing Your First Faculty Position
Early (Student, Resident, Trainee, Postdoc Fellow) Career Level
  • Finding Good Fits in Fellowship & Faculty Positions
  • Negotiation and Contracts
11:30 AM – 12:30 PM
11:45 AM – 12:15 PM
12:30 PM – 1:45 PM
2:00 PM – 3:00 PM
3:00 PM – 5:00 PM
Cerebrovascular Disease & Interventional Neurology
  • Direct to Angio Suite: The Good, the Bad, and the Evidence
  • Post-stroke Dysphagia: Implications & Innovative Therapeutic Approaches
  • Racial, Ethnic & Economic Disparities in Stroke Care: The Past & the Future
Dementia and Aging
  • Clinical and Research Applications of High Affinity Tau Imaging Agents
  • DIAN-TU Prevention Trial of Solanezumab and Gantenerumab
  • Heterogeneity in Dementia
  • Competency Based Education - Neurology Subspecialty Fellowship Perspective
  • Measuring Competence Across the Continuum: Assessment of Learners Using EPAs and Milestones
Health Services Research
  • Advances and Challenges of Patient-Reported Outcomes Data to Track and Improve Provider and Patient Experiences
  • Interdisciplinary Home Visits for People with Advanced Parkinson's Disease and Related Disorders
  • Teleneurology Metrics
5:15 PM – 6:00 PM
6:00 PM – 7:30 PM
Thursday, October 8, 2020 – Friday, October 9, 2020
Friday, October 9, 2020
8:00 AM – 5:30 PM
10:00 AM – 12:00 PM
12:30 PM – 1:45 PM
Clinical Genetic Testing For Parkinson’s Disease: What, When And How
  • Clinical Genetic Testing for Parkinson's Disease: What, When and How
  • Counseling and Ethical Issues in Genetic Testing for People with PD and their Family Members
  • Overview of PD Genetics: Common Mutations, Variance in Geographic Prevalence and Penetrance
The 2020 NINDS Strategic Plan: A Progress Report and Request for Input
  • Opportunities within the NINDS Intramural Program
  • Planning Strategically: Ushering Neuroscience Into the Future
2:00 PM – 3:00 PM
Emerging Scholar Lectures 4 (NEW!)
  • Gamma Sensory Flicker for Patients with Prodromal Alzheimer’s Disease: A Phase I Trial
  • In-vivo Two-photon Imaging Reveals Brain Capillary Plugging During Neurotoxicity in a Mouse Model of Chimeric Antigen Receptor (CAR) T Therapy
  • Non-invasive Calcium Imaging Reliably Classifies Sleep States
  • Observing Patterns in MRI with QSM in Patients with SOD1 Genetic ALS
3:30 PM – 5:30 PM
Movement Disorders
  • Genetics of PD
  • Update on Huntington Disease
  • Update on Inherited Ataxias
  • Brain Tumor Immunotherapy
  • Paraneoplastic Syndromes and Neurologic Autoimmunity in the era of Cancer Immunotherapy
  • Update on Car-T Cell Neurotoxicity
  • ALS: Lessons from 10,000 Genomes
  • CMT Genomics Informs Pathways to Therapies
  • Cell Based Functional Screens to Resolve Genetic Variants
Sleep Disorders & Circadian Rhythms
  • Clinical and Genetic Aspects of Human Circadian Phenotypes
  • Does Mechanism Matter? Choosing Among Insomnia Treatments
  • Take a Nap, Change your Mind: Sleep and Cognition
5:30 PM – 6:00 PM
6:00 PM – 7:30 PM